Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4635291
Max Phase: Preclinical
Molecular Formula: C32H23NO11
Molecular Weight: 597.53
Molecule Type: Unknown
Associated Items:
ID: ALA4635291
Max Phase: Preclinical
Molecular Formula: C32H23NO11
Molecular Weight: 597.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CCOc1ccc2c(c1O)C(=O)c1c3c(cc(O)c1C2=O)[C@@]12O[C@@]1([C@](C)(O)[C@@H](O)C(=O)OC)[C@H](C#C/C=C\C#C[C@H]2O)N3
Standard InChI: InChI=1S/C32H23NO11/c1-4-13-43-18-12-11-15-21(26(18)37)27(38)23-22(25(15)36)17(34)14-16-24(23)33-19-9-7-5-6-8-10-20(35)31(16)32(19,44-31)30(2,41)28(39)29(40)42-3/h1,5-6,11-12,14,19-20,28,33-35,37,39,41H,13H2,2-3H3/b6-5-/t19-,20+,28-,30+,31-,32+/m0/s1
Standard InChI Key: CKFSRLNTPDHQJR-DNZMGCGRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 597.53 | Molecular Weight (Monoisotopic): 597.1271 | AlogP: -0.13 | #Rotatable Bonds: 5 |
Polar Surface Area: 195.38 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.46 | CX Basic pKa: | CX LogP: 2.83 | CX LogD: 2.80 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.10 | Np Likeness Score: 1.56 |
1. Adhikari A, Teijaro CN, Yan X, Chang CY, Gui C, Liu YC, Crnovcic I, Yang D, Annaval T, Rader C, Shen B.. (2020) Characterization of TnmH as an O-Methyltransferase Revealing Insights into Tiancimycin Biosynthesis and Enabling a Biocatalytic Strategy To Prepare Antibody-Tiancimycin Conjugates., 63 (15): [PMID:32658465] [10.1021/acs.jmedchem.0c00799] |
Source(1):